台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    91.8
  • 漲跌
    ▲0.9
  • 漲幅
    +0.99%
  • 成交量
    337
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-口袋 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

口袋 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/2800.00398.60100.00-3312-0.96%
2024/05/27198.0000.00100.0013070.33%
2024/05/24199.4000.00105.0012980.33%
2024/05/23297.40290.50100.5002860.00%
2024/05/21286.2000.0093.0022500.80%
2024/05/1400.00674.2574.30-6249-2.41%
2024/05/1300.00475.1374.00-4258-1.55%
2024/03/29169.5000.0069.5012440.41%
2024/03/28168.6000.0069.5012440.41%
2024/03/1500.00157.9058.60-1225-0.44%
2024/03/0800.00059.0061.0002140.00%
2024/03/04558.0000.0060.2051932.59%
2024/02/26552.0000.0052.1051812.76%
2024/02/2100.000.248.3047.00-0.2182-0.10%
2024/02/150.255.4000.0055.500.21770.10%
2024/02/0500.00149.1050.50-1164-0.61%
2024/02/01147.5000.0043.8511530.65%
2023/11/17139.8500.0039.9011770.56%
2023/11/1300.001131.0534.20-11154-7.12%
2023/11/0300.001829.9530.00-18140-12.80%
2023/10/301132.3900.0031.50111298.48%
2023/10/201829.0000.0029.00188221.69%
2023/10/1900.00228.0028.30-279-2.51%
2023/10/18228.05028.0528.052712.81%
2023/10/1300.000.323.1524.10-0.330-0.82%
2023/09/040.220.0000.0021.000.2450.33%
2023/06/190.121.8000.0021.700.11040.10%
2023/06/0200.000.323.1023.10-0.3121-0.24%
2023/05/2300.00120.9520.85-1111-0.90%
2023/05/220.120.1000.0020.350.11100.13%
2023/05/190.120.1000.0020.100.11090.13%
2023/04/24019.7500.0020.0001010.00%
2023/03/21019.4500.0019.200620.00%
2023/03/16119.7000.0019.901492.03%
2023/02/22015.9500.0016.500130.01%
2022/04/1800.00116.5516.95-192-1.08%
2021/10/1300.00115.3515.20-183-1.19%
2021/05/14218.9500.0017.9024590.44%
2021/03/0200.00118.2017.40-1256-0.39%
2021/02/26118.1500.0018.1512300.43%
2020/11/0200.002018.8818.65-20470-4.25%
2020/10/202019.0000.0019.80205463.66%
2020/09/1500.00119.3519.15-11,377-0.07%
2020/09/10119.4500.0019.2511,4690.07%
2020/09/0800.00220.0019.95-21,649-0.12%
2020/09/02220.4000.0020.3521,8770.11%
2020/09/0100.00120.3520.25-11,895-0.05%
2020/08/2000.00519.9519.70-52,121-0.24%
2020/08/1200.00124.1023.80-12,327-0.04%
2020/08/06124.3500.0024.3012,3020.04%
2020/07/23528.6000.0028.8052,2330.22%
2020/07/22130.0000.0030.0012,2040.05%
2020/07/1600.00129.9029.05-12,018-0.05%
2020/07/15131.0000.0030.8011,9830.05%
2020/07/0700.00121.3021.60-11,505-0.07%
2020/06/1800.00122.9022.85-11,372-0.07%
2020/06/17125.40625.3825.35-51,350-0.37%
2020/06/16425.25225.8325.9021,2940.15%
2020/06/15224.0000.0024.2021,2070.17%
2020/06/12121.2000.0022.0011,1240.09%
2020/06/11220.70120.9021.0011,0770.09%
2020/06/10118.2000.0019.1019850.10%
2020/05/2700.00121.6019.45-1947-0.11%
2020/05/25119.1500.0019.6519350.11%
2020/05/1100.00111.8011.40-1781-0.13%
2020/05/05112.4500.0012.4017420.13%
2020/03/0600.00114.8014.75-1502-0.20%
2020/02/25112.5000.0012.8012640.38%
2019/11/0400.00110.0510.05-187-1.14%
2019/07/18112.1000.0012.2011230.81%
2019/02/1200.00112.4012.95-1116-0.86%
2019/01/14113.8000.0014.001941.06%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音